Featured Publications

Leveraging a deep bench of expertise and foundational experience in DNA medicine development, we’re driving research that has the potential to transform treatment paradigms and improve patients’ lives.


Title Disease Target Product
Immunogenicity of a DNA vaccine candidate for COVID-19
Nature Communications — May 2020
COVID-19 INO-4800
571. Safety and Immunogenicity of INO-4800, a COVID-19 DNA Vaccine as a Primary Series and Booster
Open Forum Infectious Diseases — December 2021
COVID-19 INO-4800
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
The Journal of Infectious Diseases — January 2022
COVID-19 INO-4800
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
npj Vaccines — October 2021
COVID-19 INO-4800
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
Human Vaccines & Immunotherapeutics — November 2023
COVID-19 INO-4800